Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitochondrial apoptosis is induced by Alkoxy phenyl-1-propanone derivatives through PP2A-mediated dephosphorylation of Bad and Foxo3A in CLL
Authors
Keywords
-
Journal
LEUKEMIA
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-23
DOI
10.1038/s41375-018-0288-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Frontline Therapy of CLL: Evolving Treatment Paradigm
- (2018) Craig S. Boddy et al. Current Hematologic Malignancy Reports
- Bax, Bak and beyond - mitochondrial performance in apoptosis
- (2017) Aida Peña-Blanco et al. FEBS Journal
- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- Bruton’s tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia
- (2017) J Deng et al. LEUKEMIA
- From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors
- (2017) Avi Ashkenazi et al. NATURE REVIEWS DRUG DISCOVERY
- Apoptotic foci at mitochondria: in and around Bax pores
- (2017) Begoña Ugarte-Uribe et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
- (2017) Elena Tibaldi et al. HAEMATOLOGICA
- Chronic lymphocytic leukaemia
- (2017) Thomas J. Kipps et al. Nature Reviews Disease Primers
- Venetoclax: A novel B-cell lymphoma-2 inhibitor for chronic lymphocytic leukemia and other hematologic malignancies
- (2017) Jacqueline L Olin et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- B cell receptor inhibition as a target for CLL therapy
- (2016) Deepa Jeyakumar et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- BCR signaling inhibitors differ in their ability to overcome Mcl-1-mediated resistance of CLL B cells to ABT-199
- (2016) K. Bojarczuk et al. BLOOD
- Combination of Targeted Drugs to Control Chronic Lymphocytic Leukemia
- (2016) Paula Cramer et al. CANCER JOURNAL
- Bcl-2 proteins in development, health, and disease of the hematopoietic system
- (2016) Matthias Kollek et al. FEBS Journal
- Second-generation inhibitors of Bruton tyrosine kinase
- (2016) Jingjing Wu et al. Journal of Hematology & Oncology
- Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
- (2016) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted Therapy of CLL
- (2016) Othman Al-Sawaf et al. Oncology Research and Treatment
- Carbon monoxide released by CORM-401 uncouples mitochondrial respiration and inhibits glycolysis in endothelial cells: A role for mitoBKCa channels
- (2015) Patrycja Kaczara et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Lyn sustains oncogenic signaling in chronic lymphocytic leukemia by strengthening SET-mediated inhibition of PP2A
- (2015) F. Zonta et al. BLOOD
- BCL-2 Antagonism to Target the Intrinsic Mitochondrial Pathway of Apoptosis
- (2015) C. J. Gibson et al. CLINICAL CANCER RESEARCH
- The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL
- (2015) K Balakrishnan et al. LEUKEMIA
- Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
- (2015) Jan A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Bim in Health and Disease
- (2015) Ronit Vogt Sionov et al. Oncotarget
- Regulation of PP2A by Sphingolipid Metabolism and Signaling
- (2015) Joshua Oaks et al. Frontiers in Oncology
- FOXO3-mediated up-regulation of Bim contributes to rhein-induced cancer cell apoptosis
- (2014) Jiao Wang et al. APOPTOSIS
- Phenothiazines induce PP2A-mediated apoptosis in T cell acute lymphoblastic leukemia
- (2014) Alejandro Gutierrez et al. JOURNAL OF CLINICAL INVESTIGATION
- Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
- (2014) Richard R. Furman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia
- (2013) F. Zonta et al. BLOOD
- Hsp90, an unlikely ally in the war on cancer
- (2013) Jared J. Barrott et al. FEBS Journal
- Apoptosis Regulation at the Mitochondrial Outer Membrane
- (2013) Laura A. Gillies et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- MBNL1 42 and MBNL1 43 gene isoforms, overexpressed in DM1-patient muscle, encode for nuclear proteins interacting with Src family kinases
- (2013) A Botta et al. Cell Death & Disease
- A review of the role of Puma, Noxa and Bim in the tumorigenesis, therapy and drug resistance of chronic lymphocytic leukemia
- (2012) L-N Zhang et al. CANCER GENE THERAPY
- Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
- (2012) Sahar A. Saddoughi et al. EMBO Molecular Medicine
- BH3-only proteins in apoptosis at a glance
- (2012) L. Happo et al. JOURNAL OF CELL SCIENCE
- FoxO transcription factors; Regulation by AKT and 14-3-3 proteins
- (2011) Guri Tzivion et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- B-cell receptor signaling in chronic lymphocytic leukemia
- (2011) F. K. Stevenson et al. BLOOD
- Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt
- (2011) J.-i. Sakamaki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BH3-only proteins: Orchestrators of apoptosis
- (2010) Aisha Shamas-Din et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Hsp90: A Drug Target?
- (2010) Jeffrey M. Holzbeierlein et al. Current Oncology Reports
- Mitochondrial cell death effectors
- (2009) Dirk Brenner et al. CURRENT OPINION IN CELL BIOLOGY
- Akt is activated in chronic lymphocytic leukemia cells and delivers a pro-survival signal: the therapeutic potential of Akt inhibition
- (2009) J. Zhuang et al. HAEMATOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started